Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29CA066124-02
Application #
2109371
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1995-02-01
Project End
2000-01-31
Budget Start
1996-02-01
Budget End
1997-01-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Wierdl, Monika; Wall, Amelia; Morton, Christopher L et al. (2003) Carboxylesterase-mediated sensitization of human tumor cells to CPT-11 cannot override ABCG2-mediated drug resistance. Mol Pharmacol 64:279-88
Wierdl, Monika; Morton, Christopher L; Harris, Linda C et al. (2003) p53-mediated regulation of expression of a rabbit liver carboxylesterase confers sensitivity to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11). J Pharmacol Exp Ther 304:699-705
Morton, C L; Potter, P M (2000) Comparison of Escherichia coli, Saccharomyces cerevisiae, Pichia pastoris, Spodoptera frugiperda, and COS7 cells for recombinant gene expression. Application to a rabbit liver carboxylesterase. Mol Biotechnol 16:193-202
Morton, C L; Wierdl, M; Oliver, L et al. (2000) Activation of CPT-11 in mice: identification and analysis of a highly effective plasma esterase. Cancer Res 60:4206-10
Pawlik, C A; Iyengar, R V; Krull, E J et al. (2000) Use of the ornithine decarboxylase promoter to achieve N-MYC-mediated overexpression of a rabbit carboxylesterase to sensitize neuroblastoma cells to CPT-11. Mol Ther 1:457-63
Potter, P M; McKenzie, P P; Hussain, N et al. (2000) Construction of adenovirus for high level expression of small RNAs in mammalian cells. Application to a Bcl-2 ribozyme. Mol Biotechnol 15:105-14
Wierdl, M; Morton, C L; Danks, M K et al. (2000) Isolation and characterization of a cDNA encoding a horse liver butyrylcholinesterase: evidence for CPT-11 drug activation. Biochem Pharmacol 59:773-81
Morton, C L; Wadkins, R M; Danks, M K et al. (1999) The anticancer prodrug CPT-11 is a potent inhibitor of acetylcholinesterase but is rapidly catalyzed to SN-38 by butyrylcholinesterase. Cancer Res 59:1458-63
Potter, P M; Pawlik, C A; Morton, C L et al. (1998) Isolation and partial characterization of a cDNA encoding a rabbit liver carboxylesterase that activates the prodrug irinotecan (CPT-11). Cancer Res 58:2646-51
Potter, P M; Wolverton, J S; Morton, C L et al. (1998) Cellular localization domains of a rabbit and a human carboxylesterase: influence on irinotecan (CPT-11) metabolism by the rabbit enzyme. Cancer Res 58:3627-32

Showing the most recent 10 out of 14 publications